Neuracle Science is developing therapeutic antibody candidates aimed at treating neurodegenerative diseases by constructing new synaptic connections.

Vision and Mission: Their mission is to bridge the gaps in neurodegenerative brain health, with a vision to provide disease-modifying treatments and expand breakthrough therapies.

Noteworthy Points:

• Founded in 2015 with a focus on neurodegenerative diseases.
• Currently in IPO registration status.
• Conducting clinical trials for their leading therapeutic candidates.